Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly R Ostler

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Reviews on Recent Clinical Trials|May 14, 2008
Implications of FLT3 mutations in the therapy of acute myeloid leukemiaRyan J Mattison, Kelly R Ostler, Frederick L Locke, et al.
Leukemia & Lymphoma|September 4, 2008
The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cellsOzden Ozer, Yi D Zhao, Kelly R Ostler, et al.
BMC Cancer|June 16, 2010
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell linesQiwei Yang, Yufeng Tian, Kelly R Ostler, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 30, 2011
Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancerColleen L Doçi, Tanmayi P Mankame, Alexander Langerman, et al.
Epigenetics|March 8, 2012
Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemiaJumpei Yamazaki, Rodolphe Taby, Aparna Vasanthakumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2011
Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stageAnna Woloszynska-Read, Wa Zhang, Jihnhee Yu, et al.
Cancer Research|May 15, 2015
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic LeukemiaJumpei Yamazaki, Jaroslav Jelinek, Yue Lu, et al.
Cancer Research|July 1, 2010
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesisMrinal Y Shah, Aparna Vasanthakumar, Natalie Y Barnes, et al.
Cancer Research|July 21, 2012
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastomaKelly R Ostler, Qiwei Yang, Timothy J Looney, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Reviews on Recent Clinical Trials|May 14, 2008
Implications of FLT3 mutations in the therapy of acute myeloid leukemiaRyan J Mattison, Kelly R Ostler, Frederick L Locke, et al.
Leukemia & Lymphoma|September 4, 2008
The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cellsOzden Ozer, Yi D Zhao, Kelly R Ostler, et al.
BMC Cancer|June 16, 2010
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell linesQiwei Yang, Yufeng Tian, Kelly R Ostler, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 30, 2011
Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancerColleen L Doçi, Tanmayi P Mankame, Alexander Langerman, et al.
Epigenetics|March 8, 2012
Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemiaJumpei Yamazaki, Rodolphe Taby, Aparna Vasanthakumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2011
Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stageAnna Woloszynska-Read, Wa Zhang, Jihnhee Yu, et al.
Cancer Research|May 15, 2015
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic LeukemiaJumpei Yamazaki, Jaroslav Jelinek, Yue Lu, et al.
Cancer Research|July 1, 2010
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesisMrinal Y Shah, Aparna Vasanthakumar, Natalie Y Barnes, et al.
Cancer Research|July 21, 2012
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastomaKelly R Ostler, Qiwei Yang, Timothy J Looney, et al.
Pageof 1